Last Round
Series C
May 18, 2026
Total Funding Raised
$50M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Accro Bioscience Inc. is a clinical-stage biotechnology company that pioneers the discovery, development, and commercialization of novel therapeutics for inflammatory and autoimmune diseases by targeting molecular mechanisms of regulatory cell death.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accro Bioscience Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Accro Bioscience Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 18, 2026 |
Accro Bioscience Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TCG Crossover | Series C |
| Centurium Capital | Series C |
| Oriza Holdings | Series C |
| Yuanhe Holdings | Series C |
| Shenzhen Capital Group | Series C |
| OrbiMed | Series C |
| Cenova Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
$50M round led by OrbiMed.
- Apr 7, 2026
Monthly visitors increased 129% MoM.
Accro Bioscience Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Accro Bioscience Inc.'s valuation, stock price, and market status.